Genemod LIMS & ELN Overview: Features, Pricing & Who It’s For (2026)

Genemod is a Seattle-area software company that builds a unified LIMS and ELN platform for life science research labs. Founded in 2017 or 2018 (Tracxn and PitchBook report slightly different dates) by Jacob Lee (CEO) and Jin Choe (CTO), the company has raised $7.22 million across three funding rounds, with a $4.5 million Seed round closing in May 2023 led by Defy and LDV Partners (Tracxn). Other investors include Canaan, Cercano Management, Dolby Family Ventures, and Looking Glass Capital (PitchBook, 8 investors total). The company participated in SLAS 2024, one of the primary lab automation and screening conferences in the industry.

Genemod’s core pitch is consolidation: replace the fragmented mix of Excel spreadsheets, Google Docs, physical freezer logs, and paper notebooks that most small and mid-size labs still operate on, and do it in a single cloud-native platform at a price point below the enterprise LIMS market. The platform manages 10 million+ records (genemod.net homepage). Its most praised feature — confirmed across every independent review source — is the visual freezer management system, which replicates the physical layout of a lab’s freezers on-screen.

This article draws on genemod.net (all product, pricing, solutions, and FAQ pages), Tracxn, PitchBook, Crunchbase, G2, Capterra, Sourceforge, the Labsistant competitor pricing page (March 2026 verification, attributed as competitor-authored), and the Genemod pricing FAQ. Genemod has not reviewed, sponsored, or paid for this article.

Company and funding context

Understanding Genemod’s stage and scale is the most important context for a lab manager making a purchasing decision. This is a seed-stage startup, not a mature software company with decades of development behind it. Tracxn lists approximately 2 employees as of December 2024 (this appears to undercount; PitchBook lists 13 total employees, which is more consistent with an active multi-product software company). The company has raised $7.22M in total funding — meaningful for a seed stage, but modest relative to Benchling ($900M+) or even Scispot ($2.8M ARR on smaller funding).

For lab managers, the practical implications of Genemod’s stage are:

• Responsiveness and flexibility: Multiple independent reviewers on both G2 and Capterra describe the Genemod team as unusually responsive — building requested features quickly and answering support questions within hours. This is a characteristic advantage of small, founder-led software companies.
• Product evolution: The platform has a rapidly evolving roadmap. Features that reviewers noted as missing have often been added in subsequent months. This is a double-edged quality: the product improves quickly, but it is also not fully mature.
• Vendor risk: A seed-stage company with $7.22M raised and a small team carries more vendor continuity risk than a publicly traded company or a PE-backed roll-up. Lab managers signing multi-year contracts should consider data export and migration policies before committing.

At a glance

What Genemod does — platform by module

Genemod’s platform is organised around six functional areas, all available within a single cloud environment. The strength of each area is not uniform: inventory management is mature and heavily validated by user reviews; the ELN is newer and improving; the AI layer is early-stage.

1. Virtual freezer management and inventory (the core differentiator)

This is Genemod’s most differentiated and most consistently praised feature. The virtual freezer replicates the physical layout of a lab’s actual freezers — rack by rack, shelf by shelf, box by box — in a visual on-screen interface. Scientists drag samples into their correct positions digitally, and the system maintains a real-world mirror of what is stored where. A Capterra reviewer who came from -80°C freezer management describes it as: “This software is useful for users who prefer better visualizations of real-life environment. Very easy to manage sample data.”

Beyond freezers, the inventory module covers: reagent management with customisable item types (presets for common reagent categories, fully custom types for unusual materials); consumable management organised by category and location; advanced search with filters, sorting, and ranking to locate any reagent across any freezer in seconds; automatic expiry tracking with alerts when reagents approach expiration; low-stock alerts; and a complete activity log (audit trail) for all inventory actions.

The most direct competitive comparison is with labs that manage inventory in multiple Excel spreadsheets — which Capterra reviewers confirm is the most common prior state. A Capterra reviewer: “Switching from a bunch of Excel spreadsheets to its inventory management features has really streamlined our research process.” A G2 reviewer confirms the same transition: “We used excel spreadsheets and google docs for inventory management and report generation, but Genemod LIMS & ELN helped to accelerate our research.”

2. Electronic Lab Notebook (ELN)

The ELN was added as a second major feature layer and has become a primary driver for labs that switch from commercial ELNs to Genemod’s integrated platform. A Capterra reviewer: “We recently started to use Genemod’s ELN as well, and it helped us save a lot of budget by stopping the use of another ELN that we had been using for years.”

Confirmed ELN features from genemod.net/eln-software: real-time collaborative editing with live updates (multiple users working simultaneously); flexible protocol and experiment templates that teams can share and reuse; rich text and multimedia documentation; internal messaging and commenting directly on experiment records; version control with automatic versioning on all updates; and folder-based organisation for projects and files. The ELN is described as “a user-friendly digital lab workspace” on the pricing page.

The ELN integrates directly with the LIMS inventory: scientists can link reagents and samples from the inventory directly into experiment records, creating traceable connections between what was used and what was observed. This is the core value of a unified LIMS+ELN versus two separate systems — and it is the architectural choice that distinguishes Genemod from labs running separate inventory and ELN tools.

3. Order management

A centralised order management dashboard tracks all purchase requests and their current status in one place. Scientists submit order requests through Genemod; lab managers receive notifications and can approve or process orders. This closes the loop between inventory depletion (tracked in the LIMS) and procurement: when a reagent stock falls below a threshold, a low-stock alert triggers an order request in the same system. No separate procurement tracking in email or spreadsheets.

4. Equipment scheduling and management

A visual equipment availability calendar shows which instruments are booked and when, allowing scientists to schedule time on shared equipment without conflicts. Maintenance tracking is also supported. A G2 reviewer specifically praises the equipment scheduling as a differentiating feature: “It integrates the reservation of equipment, laboratory notebook, and management of the freezer and consumables of the laboratory in a single platform.” Instrument availability at a glance, integrated with the rest of the lab management system, is a common pain point for labs sharing expensive instruments across multiple teams.

5. AI Agent LIMS

Genemod has launched an AI layer described as an “AI Agent LIMS” (genemod.net/products/ai-lims). Confirmed capabilities include: in-platform workflow support and guidance for any task; automated spreadsheet column matching for data imports (reducing manual mapping effort); AI-driven recommendations for routine tasks; and real-time analytics across lab operations. The AI features are positioned as reducing setup friction for new data imports and providing data-driven insights from existing lab records. This is an early-stage feature set, and no independent user validation of AI-specific outcomes is available as of April 2026. Lab managers should evaluate AI features in trial rather than treating them as production-ready capabilities without their own validation.

6. Compliance and audit infrastructure

Genemod’s compliance infrastructure covers the requirements relevant to its primary market — R&D and early-stage regulated environments. Confirmed features: built-in audit trails for all actions (who changed what, when), version control across all records, 21 CFR Part 11 compliance support, and role-based access controls. The FAQ states that 21 CFR Part 11 compliance is supported and that the AWS infrastructure carries ISO 27001, SOC 1, and SOC 2 certifications.

An important distinction for regulated lab managers: the AWS infrastructure certifications (SOC 2, ISO 27001) confirm that Amazon’s data centres and core services meet those security standards. This is different from a product-level SOC 2 Type II certification for Genemod’s own application and processes, which is what platforms like Revvity Signals Notebook carry. Lab managers in regulated environments (GxP, FDA-audited facilities) should ask Genemod specifically whether they hold their own product-level SOC 2 Type II report and what IQ/OQ/PQ validation documentation is available.

Pricing

Genemod’s pricing is more transparent than most enterprise LIMS vendors in this series. Key confirmed facts:

• Starting price: approximately $199/month (Sourceforge; Labsistant competitor page, March 2026, attributed as competitor-authored). Annual contract required.
• 4 tiers (Labsistant, March 2026). The tiers correspond to different feature sets and scale levels. The Team plan for Industry is described by Genemod’s own FAQ as “geared towards startups” and offering “our most popular features.”
• Annual contracts required: All plans. “All Genemod plans currently require annual contract commitments” (genemod.net/pricing/common/FAQ, confirmed).
• 14-day free trial (Labsistant competitor page, March 2026). The Krowdbase listing says “no free trial,” which may reflect an older state. Lab managers should verify current trial availability directly at genemod.net.
• No permanent free tier: Unlike eLabFTW (free, open-source) or some freemium competitors. Genemod is a paid SaaS product.
• Academia plan: Available for .edu email addresses. Up to 10 users. Discounted. Requires application (genemod.net/pricing/common/Academia). Confirmed for new customers only.
• Multi-year discounts: Available for longer commitments (FAQ).
• Academic discount: Separate from the Academia plan; discounted pricing available for academic labs and institutions (FAQ).

Who Genemod is designed for

Genemod’s design choices — visual freezer interface, unified LIMS+ELN, cloud-native SaaS, affordable pricing, startup-responsive support — define a very clear buyer profile:

• Biotech startups and early-stage biopharma companies that are currently managing inventory in Excel or Google Sheets and need a purpose-built system without enterprise LIMS complexity or pricing. Multiple Capterra and G2 reviewers confirm this is Genemod’s most natural customer: labs coming from spreadsheets, not from a legacy LIMS.
• Academic research labs and university groups with .edu email eligibility for the Academia plan. Genemod offers a cheaper path to unified inventory and ELN than most commercial alternatives at academic pricing levels.
• Labs managing physical sample collections — biobanks, biorepositories, cell line libraries, reagent banks — where the visual freezer interface and spatial tracking provide concrete operational value daily.
• Life science R&D teams that previously managed ELN and inventory in separate systems and want to consolidate onto one platform. The Capterra review confirming an ELN switch away from a previously paid ELN to Genemod’s built-in ELN is the clearest evidence of this use case.
• Labs in early-stage regulated environments where 21 CFR Part 11 audit trail support and version control are required, but full GxP validation with IQ/OQ/PQ documentation is not yet the primary driver.
• Diagnostics companies processing daily sample volumes that need automated barcoding, batching, PCR/sequencing/immunoassay workflow customisation, and real-time turnaround monitoring (genemod.net/solutions/diagnostics).

Genemod is not the right choice for:

• Labs in fully validated GxP manufacturing or quality control environments requiring vendor-provided IQ/OQ/PQ packages, a product-level SOC 2 Type II report, and a large enterprise support organisation. STARLIMS, SciCord, or Revvity Signals Notebook are more appropriate.
• Pharmaceutical analytical labs running Waters Empower or Agilent OpenLab CDS that need native instrument-data system integration. Agilent SLIMS or Waters NuGenesis are better positioned.
• Organisations that need on-premise deployment. Genemod is cloud-only.
• Labs with chemistry-intensive workflows requiring native chemical structure drawing, substructure search, and stoichiometry calculation (ChemDraw-level functionality). Revvity Signals Notebook is purpose-built for that need.
• Large multi-site enterprises needing an ELN that has been deployed at Eli Lilly, Roche, and AstraZeneca scale with global rollout track records. Genemod’s customer base, while growing, does not have publicly confirmed named enterprise deployments at that scale.

What users say

Genemod has verified reviews on both G2 and Capterra. The review base is modest in size but consistent in themes. No incentivised reviews are confirmed — both Capterra and G2 note non-incentivised verification for their review processes.

Consistent positives across all sources

• Visual freezer management: The most universally praised feature. Reviewers from multiple disciplines all return to the freezer visualisation as the primary operational value. A Capterra reviewer: “Very easy to manage sample data” coming from -80°C freezer management. A G2 reviewer: “Custom design a virtual freezer that matches its real-life counterpart, shelf for shelf and item for item.”
• Ease of use: The second most consistently cited praise. “Intuitively designed and easy to learn” (Capterra). G2 surfaces “Ease of Use” in 11 of the verified reviews. Multiple reviewers describe switching from Excel with minimal disruption.
• Support responsiveness: Described across multiple reviews as unusually fast for a software product. “Responds to any software-related questions within a few hours” (Capterra). “Genemod staff members have been quite responsive to our comments and suggestions, showing a willingness to improve the platform to tailor it to the users” (G2).
• Feature-building responsiveness: Multiple reviewers note that features they requested were actually built. “The Genemod team developed [features] to accommodate our requirements” (Capterra). “Minor limitations with the platform were quickly fixed by the Genemod staff members” (G2). This is a pattern characteristic of a small, founder-led company with a fast release cycle.
• Unified platform value: Labs integrating equipment scheduling, ELN, and inventory in a single system describe meaningful workflow improvements. A G2 reviewer: “It integrates the reservation of equipment, laboratory notebook, and management of the freezer and consumables of the laboratory in a single platform.”

Consistent criticisms

• Missing features / limited functionality: The most common negative pattern on G2 (missing features: 5 mentions; limited functionality: 4 mentions). For a young platform with an active release roadmap, this is expected — but lab managers should evaluate whether their specific workflows are fully covered now, not just in a future release.
• No mobile app (or limited mobile access): Multiple G2 reviewers note the absence of a mobile app as a gap for on-the-go access. Research.com mentions a mobile app as a Genemod feature; G2 reviewers describe it as missing or limited. Lab managers with field or mobile data entry needs should verify current mobile status directly with Genemod.
• Access limitations: G2 surfaces “access limitations” (3 mentions) and “limited access” (2 mentions) as negative themes, suggesting some users find the permission/role system more restrictive than expected. Worth evaluating during the trial for labs with complex access control requirements.
• Data management issues: 2 mentions on G2. The specific nature is not confirmed without reading individual reviews. Lab managers should probe this during evaluation.

Quick verdict

Further reading

• Genemod official website
• Genemod LIMS product overview
• Genemod ELN product overview
• Genemod AI Agent LIMS
• Genemod pricing and FAQ
• Genemod Academia plan
• Genemod pricing FAQ (contracts, data backup, compliance)
• Genemod on G2 — verified reviews
• Genemod on Capterra — verified reviews
• Genemod funding profile — Tracxn
• Genemod at SLAS 2024
• labsoftwareguide.com: Best LIMS Software 2026
• labsoftwareguide.com: How to choose a LIMS